Seminars in Cancer Biology

Yet unrevealed aspects of histamine: questions from outside–answers at inside?
pp. 1-2(2)
Authors: László V.; Falus A.

H2-antagonists in the treatment of colon and breast cancer
pp. 3-10(8)
Authors: Bolton E.; King J.; Morris D.L.

Histamine in brain development and tumors
pp. 11-14(4)
Authors: Panula P.; Lintunen M.; Karlstedt K.

Histamine as an autocrine growth factor: an unusual role for a widespread mediator
pp. 15-23(9)
Authors: Rivera E.S.; Cricco G.P.; Engel N.I.; Fitzsimons C.P.; Martín G.A.; Bergoc R.M.

Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine
pp. 25-28(4)
Authors: Molnár E.L.; Hegyesi H.; Tóth S.; Darvas Z.; László V.; Szalai C.; Falus A.

Adjuvant histamine in cancer immunotherapy
pp. 29-39(11)
Authors: Hellstrand K.; Hansson M.; Hermodsson S.

H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells
pp. 41-45(5)
Authors: Radvány Z.; Darvas Z.; Kerekes K.; Prechl J.; Szalai C.; Pállinger E.; Valéria L.; Lia Varga V.; Sandor M.; Erdei A.; Falus A.

Interaction of histamine and other bioamines with cytochromes P450: implications for cell growth modulation and chemopotentiation by drugs
pp. 47-53(7)
Authors: LaBella F.S.; Brandes L.J.

Involvement of polyamines in apoptosis. Facts and controversies: effectors or protectors?
pp. 55-68(14)
Authors: Schipper R.G.; Penning L.C.; Verhofstad A.A.J.